Methodology comparison

Equity Rank vs StockUnlock

19 valuation methods and unlimited screening versus 7 metrics and 3 searches per week. Both tools aim to identify undervalued stocks — the depth of analysis is different.

Try Equity Rank free for 7 daysRead the full methodology
Equity Rank
  • 19 valuation methods — DCF, Graham, Residual Income, EVA, Reverse DCF, DDM, and more
  • Unlimited screener searches — no weekly cap, ever
  • Sector-calibrated SAVE Score — technology vs. utilities vs. REITs scored differently
  • Options screener built in — IV percentile, real chain data, earnings play flags
  • Full methodology at /methodology — every weight and formula disclosed
StockUnlock
  • 7 valuation metrics on free tier — no multi-method triangulation
  • 3 screener searches per week on free — designed to push upgrades
  • 100K+ global stocks — breadth across 70+ exchanges
  • No options analysis
  • Scoring formula not publicly documented

Feature-by-feature comparison

FeatureEquity RankStockUnlock
Valuation methods per stock19 methods — DCF, P/E, EV/EBITDA, DDM, Graham, P/S, P/B, Residual Income, EVA, Reverse DCF, and moreDCF + 7 ratios (P/E, P/B, P/S, EV/EBITDA, dividend yield, PEG) — no multi-method triangulation
Screener search limitUnlimited in the Pro plan — run as many screens as needed3 searches per week on the free tier — artificial scarcity
Composite scoring modelSAVE Score — Safety, Analyst, Valuation, Earnings — sector-weighted per industryAutomated analysis summary score — weighting methodology not publicly documented
Sector-calibrated multiplesYes — technology, utilities, financials, REITs, and healthcare each use industry-benchmarked thresholdsNot confirmed — no public documentation of sector-adjusted thresholds
Options analysisIV percentile, real chain data, strategy match, earnings play identification, IV-crush badgeNot available
Forward EPS + analyst revisionsIncluded in the Pro plan — forward P/E, EPS estimates, analyst revision trackingAnalyst sentiment included in score; standalone forward EPS access unclear
Screener universeRussell 3000 (US-focused, 800+ deeply scored tickers)100K+ stocks across 70+ global exchanges — breadth over depth
Brokerage integrationNot available (roadmap)SnapTrade read-only (15-day trial, then requires paid tier)
Price + margin-of-safety alertsYes — price and MoS% thresholds via emailPrice alerts only
Methodology transparencyFull formula documentation at /methodology — every SAVE weight, every method explainedNo public disclosure of scoring formula or valuation weighting
Weekly research digestPersonalized watchlist digest every Sunday — your holdings, your SAVE scoresNot confirmed in public feature documentation
Free trial7-day trial · 60-day money-back guaranteeFree tier available (3 searches/week screener limit)
Pricing$59.99/mo or $599/yr — single Pro plan, all features included$9/mo or $90/yr (Pro) — $24/mo or $240/yr (Unlimited)

StockUnlock features sourced from public documentation at stockunlock.com and independent reviews (FindMyMoat.com, April 2026). Features subject to change. This comparison is for informational purposes only and does not constitute investment advice.

What researchers say about StockUnlock

Common friction points from published reviews — and how Equity Rank addresses each.

"Only 3 screener searches per week on free — makes it frustrating to do any real research without upgrading."

Independent StockUnlock review, FindMyMoat.com, 2026

Equity Rank

Equity Rank places no search limit on screener runs. Run 50 screens in a sitting — the data is the same whether you screen once or a hundred times.

"Valuation is limited to 7 metrics — no method-by-method breakdown. You get a number, not an explanation."

User comparison review, 2026

Equity Rank

The 19-method valuation shows each model separately — DCF, Graham Number, Residual Income, Reverse DCF, and more. When methods diverge, the spread is visible, not averaged away.

"No options data at all — you have to go to a completely different tool if you want IV or chain information."

Reddit r/options composite, 2026

Equity Rank

The options screener runs daily on real yfinance chain data. IV percentile, strategy match, and earnings-play flags are built into the same research workflow — no separate tab required.

Frequently asked questions

Is there a StockUnlock alternative with no search limits?

Equity Rank offers unlimited screener searches in its single Pro plan, including during the 7-day free trial. There is no weekly cap — run as many screens as your research requires.

Does StockUnlock offer more valuation methods than Equity Rank?

No. StockUnlock surfaces 7 valuation metrics on its free tier. Equity Rank provides 19 distinct methods — DCF, Graham Number, Residual Income, Economic Value Added, Reverse DCF, Dividend Discount Model, and more. Each method is shown separately so you can see where models agree and where they diverge.

Which tool is better for US stock research?

Equity Rank is optimized for US-listed equities (Russell 3000, 800+ tickers). It applies sector-specific valuation thresholds and scores each stock across 19 methods with a composite SAVE score. StockUnlock covers more global exchanges but applies the same analytical depth to 100K+ tickers.

Does Equity Rank include options analysis like StockUnlock?

StockUnlock does not offer options analysis. Equity Rank includes a full options screener with real-time IV percentile, chain data, strategy matching (covered calls, cash-secured puts, spreads), and earnings-play identification.

When StockUnlock may be the better fit

StockUnlock covers 100K+ stocks across 70+ global exchanges including European, Asian, and emerging-market listings that Equity Rank does not currently index. If your research spans non-US equities or requires portfolio sync via brokerage integration, StockUnlock's breadth is an advantage. Equity Rank is focused on deep, sector-calibrated US analysis rather than global breadth.

Equity Rank currently covers 800+ US-listed tickers from the Russell 3000 index. International coverage is on the roadmap.

Free Weekly Update

800+ stocks re-scored every week. Delivered free every Sunday.

  • Top 5 most undervalued stocks by margin of safety — with valuation breakdown
  • Biggest score changes from the prior week across 800+ equities
  • Best options setups from the screener (covered calls, cash-secured puts)

No spam. Unsubscribe in one click.

Research and educational purposes only. Not investment advice.

19 valuation methods. Unlimited screening. No weekly cap.

Sector-calibrated SAVE scoring, options analysis, and a full methodology you can read and verify. 7-day trial · 60-day money-back guarantee.

Start your free trial

For informational purposes only. Not investment advice. Past model performance does not guarantee future results.

© 2026 Equity Rank. All rights reserved.

Equity Rank provides algorithmic stock analysis for informational purposes only. Nothing on this platform constitutes investment advice, a solicitation, or a recommendation to overweight or underweight any security. SAVE scores are generated by automated models using publicly available data and may contain errors or omissions. Past performance of any scoring methodology is not indicative of future results. Always consult a qualified financial advisor before making investment decisions. Equity Rank is not a registered investment adviser.